Concepedia

Helen Barnacle

HB

8

Publications

874

Citations

8

H-Index

1993

Active since

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

University of Cambridge

GlaxoSmithKline (United States)

University of Pennsylvania

Helen Barnacle is an author at GlaxoSmithKline (United Kingdom) specializing in medicine, asthma, and pharmacology.

Top concepts

Publications per year

1993–2017

8

Publications

8

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Helen Barnacle, Ruby Birk et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 323 citations

A Dose-Ranging Study of Fluticasone Propionate in Adult Patients With Moderate Asthma

Ronald E. Dahl, Bo Lundbäck, Jean-Luc Malo et al. · CHEST Journal · 1993 · 182 citations

, , +9

An Oral Inhibitor of p38 MAP Kinase Reduces Plasma Fibrinogen in Patients With Chronic Obstructive Pulmonary Disease

David A. Lomas, David A. Lipson, Bruce E. Miller et al. · The Journal of Clinical Pharmacology · 2011 · 112 citations

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

Henrik Watz, Helen Barnacle, Benjamin Hartley et al. · The Lancet Respiratory Medicine · 2013 · 92 citations

, , +6

A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol

Steven Pascoe, David A. Lipson, Nicholas Locantore et al. · European Respiratory Journal · 2016 · 86 citations · Full text

, , +17

Rows per page

1–5 of 8